Market research
ACB Aurora Cannabis Inc
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 249M
- P/E ratio
- Not available
- Analyst target
- 6.2264
- Dividend yield
- Not available
- Beta
- 1.34
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA05156X8504
- Market cap
- 249M
- P/E ratio
- Not available
- Analyst target
- 6.2264
- Dividend yield
- Not available
- Beta
- 1.34
About
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ACB discussion.
5 years, 4 months ago
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.0.
Based on the above factors, Aurora Cannabis Inc gets an overall score of 1/5.